Related Experiment Video
Updated: Jul 11, 2026
09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Inherited human IRAK-4 deficiency: an update
Capucine Picard1, Horst von Bernuth, Cheng-Lung Ku
1Centre d'étude des déficits immunitaires, Hôpital Necker-Enfants Malades, 149 Rue de Sèvres, Paris, 75015, France, EU. picardc@necker.fr
Immunologic Research
|October 6, 2007
Summary
Interleukin-1 receptor-associated kinase-4 (IRAK-4) deficiency causes primary immunodeficiency. This condition leads to severe bacterial infections, especially from pneumococcus.
Area of Science:
- Immunology
- Genetics
- Microbiology
Background:
- Interleukin-1 receptor-associated kinase-4 (IRAK-4) is crucial for immune signaling pathways.
- IRAK-4 mediates responses to Toll-like receptors and IL-1 receptors.
- Defects in IRAK-4 disrupt essential immune functions.
Purpose of the Study:
- To review the clinical and genetic aspects of inherited human IRAK-4 deficiency.
- To highlight the link between IRAK-4 deficiency and susceptibility to bacterial infections.
- To emphasize the significance of IRAK-4 in primary immunodeficiencies.
Main Methods:
- Literature review of inherited IRAK-4 deficiency.
- Analysis of clinical case studies.
- Summary of immunological and genetic findings.
Main Results:
- Inherited IRAK-4 deficiency is a primary immunodeficiency.
- Patients experience recurrent invasive bacterial infections.
- Invasive pneumococcal disease is a prominent manifestation.
Conclusions:
- IRAK-4 deficiency impairs the immune system's ability to fight bacterial pathogens.
- Early diagnosis and management are critical for affected individuals.
- Understanding IRAK-4's role is vital for primary immunodeficiency research.
Related Concept Videos
01:35Pedigree Analysis
Overview
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...